ESR1 and breast carcinoma: As BRET assays offer a more quantitative evaluation of SUMOylation, we compared the impact of AEs on ERα SUMOylation and transcriptional activity using a reporter vector containing the proximal enhancer of the GREB1 gene, an estrogen target in breast cancer cells (GREB1-ERE-Luc).